Oncoheroes Biosciences And Fundación Olivares: It Is Time For New And Better Therapies

por Oncoheroes Biosciences

3 years ago
Cancer, Pediatric oncologists, better therapies

Pediatric oncologists are forced to adjust adult cancer treatments for childhood cancer due to insufficient specific therapies for children with cancer.

Oncoheroes Biosciences And The Scott Carter Foundation Are Onboard To End Childhood Cancer

por Oncoheroes Biosciences

3 years ago
Childhood cancer, Scott Carter Foundation

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Because of improved tumor detection and treatment advances in recent decades, 84% of children ...

Oncoheroes Biosciences And Arms Wide Open Childhood Cancer Foundation Fighting Childhood Cancer Together

por Oncoheroes Biosciences

3 years ago
cancer in children, Oncoheroes Biosciences, Arms Wide Open Childhood Cancer Foundation

Although cancer in children is considered rare, it is the leading cause of death by disease among children in the USA.

Oncoheroes Biosciences And Swifty Foundation United Toward New Cures

por Oncoheroes Biosciences

3 years ago
Cancer, Childhood cancer, Oncoheroes Biosciences, Swifty Foundation

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S cancers.

Oncoheroes Biosciences And Kier’s Kidz Helping Kids Beat Cancer Together

por Oncoheroes Biosciences

3 years ago
children, Cancer

Every day, more than 800 children are diagnosed with cancer worldwide.

MEET A HERO: Grant, 2 year old at diagnosis

por Oncoheroes Biosciences

3 years ago
chemotherapy, healthcare facilities, childhood cancer, Oncoheroes

"Upside down," said Grant looking at himself in the mirror and pointing at his Spiderman T-shirt while standing up on a hospital bed. Grant Gossling was 2 years old when he was diagnosed with high-ris...

SHEPHERD Therapeutics and Oncoheroes Biosciences to Partner for the Discovery, Development and Commercialization of Oncology Therapeutics For Rare Cancers

por Oncoheroes Biosciences

3 years ago
Oncology Therapeutics, Rare Cancers, Oncoheroes, SHEPHERD, DELVE

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new therapies for childho...

The Gregory Foundation For Cancer Research Strengthens Their Commitment By Investing Again In Oncoheroes Biosciences

por Oncoheroes Biosciences

3 years ago
Gregory Foundation, Cancer, immunotherapies, infant leukemia, oncology

“Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and an allogeneic CAR-T, the disease was very aggressive, and he succumbed to cancer,” explained ...

Catalytic Impact Foundation Invests in Oncoheroes Biosciences Endorsing Its Unique Effort To Treat Childhood Cancers

por Oncoheroes Biosciences

3 years ago
Childhood, cancer, rare disease, CIF, healthcare

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Although pediatric cancer death rates have declined over the past four decades due to improved tu...

Oncoheroes Joins the Coalition Against Childhood Cancer (CAC2)

por Oncoheroes Biosciences

4 years ago
Childhood Cancer, CAC2, drugs, pediatric oncology

Oncoheroes today announced its organizational membership into the Coalition Against Childhood Cancer, known as CAC2, a collaborative network of organizations and individuals supporting and servicing t...

Volasertib, a potential new treatment for rhabdomyosarcoma, receives Orphan Drug Designation from the U.S. FDA

por Oncoheroes Biosciences

4 years ago
Volasertib, rhabdomyosarcoma, childhood cancer

Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to vo...

Talk to Ricardo Garcia at BIO Investor Forum Digital, Oct 13-15

por Oncoheroes Biosciences

4 years ago
BIO Investor Forum Digital, biotech investor, pediatric cancer

As many other events this year, Bio Investors Forum (Oct 13-15) is going remote. This is a unique opportunity where international biotech investor meet with early and established private companies as ...